France RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

 

France RUO Immunoassay Market Size:

France RUO Immunoassay market is projected to grow at a CAGR of 10.89% from 2025 to 2030.

France RUO Immunoassay Market Trends:

The government of France launched the Health Innovation 2030 plan in 2021 with 7.5 billion euros, including more than 1 billion euros for biomedical research. This dynamic step will make France a biotech innovation leader. Under this initiative, University Hospital Institutes (UHI), with a budget of 300 million euros, selected, 12 new centers of excellence in healthcare research, care, prevention, training, and technology transfer.

These institutes are located in Paris and the Paris region (Garches, Villejuif), as well as Bordeaux, Toulouse, Nancy, Lyon, Nice, and Montpellier, with the seven existing UHIs. Each UHI specializes in its unique area and field of expertise. Additionally, a Chairs of Excellence call for projects that aim to establish 40 to 50 endowed chairs, each receiving 2 million euros, to attract researchers to France and enable them to build competitive teams on an international level.

In addition, presence of companies such as DBV Technologies, Cellectis, Biomérieux, and AB Science is also boosting the market growth. These advancements in medical research underscore a growing demand for RUO (Research Use Only) immunoassays across various research applications.

Several other key developments are also augmenting the demand for these assays. MagIA Diagnostics installed its new rapid immunological analysis device in March 2023 at TIBH as part of the MAGI@LINE project, which was subsidized by the “Grand Défi Bioproduction”. The objective of the project was to demonstrate the feasibility of monitoring and controlling the active ingredient at the bottom of the tank for bioproduction through rapid measurement.  In January 2022, the company was chosen by the Grand Défi Bioproduction (General Secretariat for Investment) through a call for projects. The project focuses on adapting its technology to transform it into a tool for measuring biomedicines. These developments will likely increase the demand for lab equipment including RUO immunoassays.

France has many prominent companies operating within the country and developing many innovative products. One such company is BioMérieux with their diagnostic solutions of systems, reagents, software, and services. In 2023, sales by different applications increased to3,674.7 € million in 2023 from 3,589.1 € million in 2022, showing a +6.6% change. The company also launched VIDAS® KUBE™ in 2023, an automated immunoassay system, for clinical laboratories and the food industry, which can deliver rapid results. This system is user-friendly, modular, compact, and environmentally friendly, featuring an innovative sleep mode that reduces energy consumption by up to 52%. It is compatible with reagents used in other VIDAS® instruments. As of late 2023, nearly 500 of these instruments have been installed. According to the company, 25,000 clinical laboratories are equipped with VIDAS® systems across 160 countries.

Meanwhile, In March 2024, Surge, headquartered in Paris, announced the successful completion of a €7.5 million fundraising round aimed at the immune system and advancing precision medicine. Surge specializes in high-dimensional immune system analysis paired with artificial intelligence for precision medicine.

Moreover, In February 2023, SGS enhanced its testing capabilities with advanced ELISA equipment, including the Freedom EVO 200 ELISA system for large-volume ELISA testing, and the Gyrolab xPlore system for conducting nanoliter-scale immunoassay tests. These key investments were announced at SGS's newly expanded bioanalytical laboratory in Poitiers, France.

France RUO Immunoassay Market Scope:

Report Metric	Details
Growth Rate	CAGR of 10.89%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Sample Type Application End-User State
Geographical Segmentation	Ile De France, Auvergne Rhone Alpes, Provence-Alpes-Cote d’Azur, Hauts-de-France, Occitanie
List of Major Companies in the France RUO Immunoassay Market	Alcatel Lucent (French) Siemens Healthineers F-Hoffmann La Roche Ltd. BioCheck, Inc Danaher
Customization Scope	Free report customization with purchase

 

France RUO Immunoassay Market Segmentation

By Product Type

• Immunoassay Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
    • Conventional
    • Manual
  • Radioimmunoassay (RIA Kits)
    • Conventional
    • Manual
  • Chemiluminescent Immunoassay (CLIA) Kits
• Immunoassay Reagents
• Microplate Reader
• Microplates
• Analyzers
  • Automated Analyzers
  • Non-Automated Analyzers
• Microplate Washers
• Others

By Sample Type

• Plasma
• Blood Serum
• Urine
• Saliva
• Cell or Tissue Culture Medium
• Others

By Application

• Oncology
• Blood Screening and Toxicology
• Infectious Disease
• Cardiology
• Allergy Diagnostic
• Rare and Emerging Condition Diagnostic
• Others

By End-User

• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies

By Regions

• Ile De France
• Auvergne Rhone Alpes
• Provence-Alpes-Cote d’Azur
• Hauts-de-France
• Occitanie

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

4.1. Product Pipeline

5. FRANCE RUO IMMUNOASSAY MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Immunoassay Kits

5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits

5.2.1.1. Conventional 

5.2.1.2. Manual

5.2.2. Radioimmunoassay (RIA Kits)

5.2.2.1. Conventional 

5.2.2.2. Manual

5.2.3. Chemiluminescent Immunoassay (CLIA) Kits

5.3. Immunoassay Reagents

5.4. Microplate Reader

5.5. Microplates

5.6. Analyzers

5.6.1. Automated Analyzers

5.6.2. Non-Automated Analyzers

5.7. Microplate Washers

5.8. Others

6. FRANCE RUO IMMUNOASSAY MARKET BY SAMPLE TYPE

6.1. Introduction

6.2. Plasma 

6.3. Blood Serum

6.4. Urine

6.5. Saliva

6.6. Cell or Tissue Culture Medium

6.7. Others

7. FRANCE RUO IMMUNOASSAY MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Blood Screening and Toxicology

7.4. Infectious Disease

7.5. Cardiology

7.6. Allergy Diagnostic

7.7. Rare and Emerging Condition Diagnostic

7.8. Others

8. FRANCE RUO IMMUNOASSAY MARKET BY END-USER

8.1. Introduction

8.2. Research and Academic Laboratories

8.3. Pharmaceutical and Biotechnology Companies

9. FRANCE RUO IMMUNOASSAY MARKET BY REGIONS

9.1. Introduction

9.2. Ile-de-France

9.2.1. By Product Type

9.2.2. By Sample Type

9.2.3. By Application

9.2.4. By End-User

9.3. Auvergne Rhone Alpes

9.3.1. By Product Type

9.3.2. By Sample Type

9.3.3. By Application

9.3.4. By End-User

9.4. Provence-Alpes-Cote d’Azure

9.4.1. By Product Type

9.4.2. By Sample Type

9.4.3. By Application

9.4.4. By End-User

9.5. Hauts-de-France

9.5.1. By Product Type

9.5.2. By Sample Type

9.5.3. By Application

9.5.4. By End-User

9.6. Occitanie

9.6.1. By Product Type

9.6.2. By Sample Type

9.6.3. By Application

9.6.4. By End-User

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Alcatel Lucent (French)

11.2. Siemens Healthineers

11.3. F-Hoffmann La Roche Ltd.

11.4. BioCheck, Inc

11.5. Danaher

11.6. DIAsource Immunoassya

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Alcatel Lucent (French)

Siemens Healthineers

F-Hoffmann La Roche Ltd.

BioCheck, Inc

Danaher

DIAsource Immunoassya